Vibramycin
/
Pay securely with Zelle
Description
Vibramycin is an antibiotic in the tetracycline class, primarily used to treat bacterial infections such as respiratory tract infections, skin infections, and certain sexually transmitted infections. It is available as an oral tablet and is a prescription medication. Patients are advised to avoid excessive sun exposure while taking Vibramycin, as it may increase the risk of sunburn. It should not be used in patients who are allergic to doxycycline or other tetracyclines.
US Market Context: Doxycycline Hyclate DR Tablet Discontinuation
According to official drug supply monitor updates under Section 506C of the FD&C Act, domestic market availability for Doxycycline Hyclate Delayed-Release (DR) Tablets faces manufacturing discontinuations and supply holds across U.S. distribution networks.
Because Doxycycline is a broad-spectrum tetracycline class antimicrobial essential for treating severe dermatological conditions (severe acne, rosacea), respiratory infections, Lyme disease, and periodontal conditions, supply disruptions create immediate treatment gaps. While specialized delayed-release formulations face domestic market exit, independent international supplies of established solid oral forms—specifically Vibramycin (Doxycycline Hyclate) and Periostat (Doxycycline Hyclate)—remain stable and fully accessible.
Alternative Solid Formulations
When reviewing care plans during a national formulation shortage or discontinuation, distinguishing administrative characteristics and clinical objectives is critical:
US Discontinuation Focus: Supply limitations directly target enteric-coated delayed-release (DR) oral tablets designed for gastrointestinal protection.
International Sourcing Options: Profarma Express facilitates access to authentic, batch-certified Vibramycin Oral Capsules/Tablets (standard antimicrobial dosing) and Periostat Oral Tablets (low-dose anti-inflammatory therapy) sourced directly from accredited European partner pharmacies.
IMPORTANT MEDICAL NOTICE: Transitioning a patient from delayed-release (DR) doxycycline to immediate-release Vibramycin or low-dose Periostat requires consideration of gastrointestinal tolerance and dosing schedules. Immediate-release formulations should be taken with a full glass of water and while standing or sitting upright to reduce the risk of esophageal irritation and ulceration. Any dosage modification must be evaluated and approved by a licensed prescribing physician.
⚠️ IMPORTANT SAFETY WARNING: FETAL HARM, TOOTH DISCOLORATION & PHOTOSENSITIVITY
PEDIATRIC & FETAL RISK: The use of tetracycline class drugs during tooth development (last half of pregnancy, infancy, and childhood up to 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown). Doxycycline should not be used during pregnancy unless explicitly required.
PHOTOSENSITIVITY: Photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Patients likely to be exposed to direct sunlight or ultraviolet light should be advised that this reaction can occur.
Clinical Applications & Administration Differences
While delayed-release tablets offered specialized enteric coatings, immediate-release Vibramycin and sub-antimicrobial Periostat cover the full therapeutic spectrum when administered with proper patient compliance guidelines:
Formulation | Primary Clinical Setting | US FDA Supply Status | International Availability |
|---|---|---|---|
Doxycycline Hyclate DR Tablets | Delayed-Release / GI Protection | ⚠️ Discontinued / Market Hold | Restricted Clinical Stock |
Vibramycin / Periostat Tablets | Standard & Anti-Inflammatory Therapy | Active Component Availability | ✅ In Stock & Ready to Ship |
Quality Assurance & Personal Importation Integrity
Authentic Sourcing: Genuine branded Vibramycin and Periostat tablets dispensed exclusively by licensed UK and European Union partner pharmacies.
Prescription Verification: Every order undergoes strict verification against a valid medical prescription by supervising licensed pharmacists.
Tracked Logistics: Temperature-monitored international shipping delivered directly to all 50 U.S. states.
Domestic U.S. availability for specific delayed-release (DR) oral solid forms has been impacted by manufacturer discontinuations reported under Section 506C FD&C Act, raw material allocation changes, and sterile packaging consolidation.
Yes, under direct physician guidance. Vibramycin contains the exact same active pharmaceutical ingredient (Doxycycline Hyclate). To prevent upper gastrointestinal irritation when switching from DR to immediate-release forms, take the medication with plenty of fluids and remain upright for at least 30 minutes.
Yes. Doxycycline is a potent prescription antimicrobial and anti-inflammatory agent. A valid medical prescription from a licensed healthcare provider is mandatory to process your order.
Under U.S. FDA personal importation enforcement discretion, U.S. residents facing domestic drug shortages or product discontinuations generally encounter no enforcement objections when importing up to a 90-day supply of essential personal prescription medications for non-commercial use, provided a valid prescription is verified by a licensed healthcare provider.
Track Other Monitored FDA Drug Deficits
🍪 We use cookies
We use cookies to enhance your browsing experience, serve personalised content, and analyse traffic. By clicking "Accept all", you consent to our use of cookies.